ZL-1311

N/A

Report date: 2026/03/19 17:03:36

Base Information

Drug NameZL-1311
Drug Alias NameZL-1311ZL1311
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionAnti-MUC17Anti-CD3
TargetsMucin-17T cell surface glycoprotein CD3
Therapy Area/IndicationsGastroesophageal Junction NeoplasmsStomach Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesZai Lab Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZai Lab Ltd
Inactive CompaniesN/A
Active IndicationsGastroesophageal Junction NeoplasmsStomach Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A